Sign in
4

Changes in Ownership

Traws Pharma, Inc. Filed Acc 0001179110-16-018082

Options or other derivatives

  • Chief Financial Officer acquired 69,984 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

BANSAL AJAY · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2016-01-26 Grant or award : show line 1 in the form Stock Option (right to purchase) +69,984 $0.65 2026-01-26 69,984 69,984 D
Loading xslF345X03/edgar.xml…